Peptide Assay Interference: Causes, Detection and Controls
Peptide assay interference is any component of a sample, reagent set or workflow that changes a measured signal without a matching change in the true amount of the target peptide. In immunoassays it usually acts on antibody binding. In LC-MS/MS it usually acts on ionization. In both formats, it can also arise before analysis, when peptide is lost to surfaces or degraded. This guide explains the main mechanisms, how a laboratory can investigate a suspect result, and which controls and documentation reduce the risk. For Research Use Only. Not for human or veterinary use.
TL;DR
- Interference produces false-high or false-low readings. The mechanism depends on the format: cross-reactivity, heterophile antibodies and the hook effect affect immunoassays, while ion suppression affects LC-MS/MS.
- Pre-analytical losses, such as adsorption to labware and proteolytic degradation, can mimic interference and should be ruled out first.
- Serial dilution, spike-recovery, blocking reagents and an orthogonal method are the standard ways to investigate a suspect result.
- Stable isotope-labeled internal standards, enrichment of target peptides and validated sample handling limit matrix effects.
- A batch-specific Certificate of Analysis (COA) helps assess reference-material identity and purity; it does not eliminate uncertainty in concentration, stability or suitability for the assay.
Table of Contents
- What peptide assay interference means
- Common causes in immunoassays
- Interference in mass spectrometry assays
- Pre-analytical artifacts that look like interference
- How to detect and investigate suspected interference
- Controls and validation that limit interference
- Perspective
- Documentation for traceable results
- Research materials from Vertex Labs
- FAQ
- Sources
What peptide assay interference means
An assay reports a signal and a calibration curve converts that signal to a concentration. Interference is anything that breaks the link between the two. In immunoassays, interference occurs when substances alter the measurable analyte concentration or antibody binding, with heterophile or human anti-mouse antibodies and cross-reactivity as typical examples.
The distinction between formats matters because the remedies differ. Immunoassays measure an indirect signal that does not by itself confirm the identity of the target. Peptide-specific detection by LC-MS/MS can avoid many immunoassay pitfalls, but mass spectrometry has its own failure modes, chiefly matrix effects.
A practical way to frame the problem is to ask where the signal can go wrong:
- Before the assay: the peptide is lost or altered during collection, storage or transfer.
- During recognition: antibodies bind something other than the intended sequence, or fail to bind the intended one.
- During detection: the label, ionization process or optical readout is altered by co-existing substances.
A troubleshooting plan that addresses all three stages is far more reliable than one that assumes the assay itself is at fault.
Common causes in immunoassays
A 2022 review of hormone immunoassay problems lists cross-reaction, endogenous antibodies, biotin, bilirubin and lipids among the common causes. Each acts differently.
Cross-reactivity
An antibody raised against one peptide may bind a structurally related sequence, a truncated fragment or a modified form. In a research setting, closely related analogs and degradation products are the usual candidates. The result is a false-high reading if the unintended species adds to the signal, or a distorted curve if it competes with the target. For a detailed look at how antibody-related interference arises and is corrected, see this overview of antibody cross-reactivity causes and fixes.
Heterophile and anti-species antibodies
Samples from some species contain antibodies that bridge the capture and detection antibodies in a sandwich format, generating signal with no analyte present. Blocking reagents containing non-immune immunoglobulin from the relevant species are the usual countermeasure, and a case report on a natriuretic peptide assay illustrates the approach: serial dilution, species-specific IgG blocking and an alternative platform were combined to confirm heterophilic interference.
Biotin, bilirubin and lipids
Assays built on streptavidin-biotin capture can be disturbed by free biotin in a sample. Pigments and lipids can scatter or absorb light in optical readouts and can change the effective sample matrix. These are matrix properties, so they show up as a lack of parallelism between diluted samples and the calibration curve.
The hook effect
The hook effect belongs to sandwich formats only. When analyte is extremely abundant, it saturates both capture and signal antibodies, preventing sandwich complexes from forming and producing falsely low results. The same review notes it can be identified by serial dilution. A reading that rises as the sample is diluted is the signature.
Interference in mass spectrometry assays
LC-MS/MS is more specific, not immune. Co-eluting matrix components can change ionization efficiency, so that ion suppression or enhancement compromises measurement. The size of the effect depends on the analyte, the fluid, the reagent formulation, the dilution and the detection design.
Two practical points follow from the literature. First, spectrum libraries are more robust when built from MS/MS data, because ion suppression can reduce the information content of full-scan spectra. Second, the sample preparation route matters. Immunoaffinity enrichment of target peptides after tryptic digestion, as in SISCAPA, digests endogenous immunoglobulins and enriches target peptides before LC-MS/MS, which removes the antibody-related interference route described above. Laboratories evaluating multiplexed or enrichment-based workflows may find the information on peptide enrichment and multiplex assay options useful when planning method development.
Pre-analytical artifacts that look like interference
Many unexplained low readings originate before the sample reaches the instrument. A 2023 tutorial review identifies nonspecific adsorption to tips, vials and tubing as a major pre-analytical artifact, particularly at low concentrations, causing significant signal loss. The same review notes that peptides are susceptible to hydrolysis, oxidation and protease activity, so collection and storage conditions must be controlled to keep concentrations unchanged between sampling and analysis.
Checks worth building into the workflow:
- Compare recovery from low-binding and standard labware at the lowest concentration in the curve.
- Prepare calibrators in the same matrix and container type as study samples.
- Record freeze-thaw cycles, hold times and temperatures for every sample.
- Where proteases are present, document the inhibitors and the point in the workflow at which they were added.
- Track aggregation, which can remove peptide from solution and shift apparent concentration. Our laboratory guide to peptide aggregation prevention covers this in detail.
Stability itself is a variable. If the reference peptide degrades between preparation and use, the calibration is wrong from the start. The peptide stability testing guide for biotech assays describes how to generate that evidence.
How to detect and investigate suspected interference
A suspect result is one that disagrees with the experimental design, with a related measurement, or with itself across dilutions. The following sequence moves from cheapest to most informative. It draws on the systematic investigation described in the natriuretic peptide case report and on the dilution logic in the hormone immunoassay review.
Step 1: Repeat and rule out handling
Repeat the measurement from a fresh aliquot with new labware. Confirm the reference material, lot and storage history. If the result changes, the cause is likely pre-analytical.
Step 2: Serial dilution
Dilute the sample in the assay diluent and compare observed with expected values. Linear dilution that tracks the expected value supports a true signal. A reading that increases on dilution points to the hook effect. In the case report, linear but incomplete recovery after dilution, meaning measured values below expectation, was consistent with antibody-mediated interference rather than genuine analyte.
Step 3: Spike-recovery
Add a known amount of the reference peptide to the sample matrix and to a clean buffer, then compare recoveries. Recovery well below or above the buffer control indicates a matrix effect. Spiking only works if the reference material has verified identity and purity, which is why we recommend recording the COA lot for every spike. Our Certificates of Analysis page explains the batch-level data we provide.
Step 4: Blocking reagents
Treat an aliquot with blocking immunoglobulin or a commercial blocker and compare with the untreated aliquot. A species-specific reduction implicates anti-species antibodies.
Step 5: Orthogonal method
Measure the same sample by a method with a different detection principle, such as LC-MS/MS against an immunoassay. Agreement strengthens confidence. Disagreement locates the problem in one of the two methods and gives a clear next question.
Step 6: Document the conclusion
Record the observation, the tests performed, the outcome and any change to the method. This record is what lets another analyst reproduce the reasoning later.
Controls and validation that limit interference
Internal standards
For mass spectrometry, stable isotope-labeled internal standards can help correct matrix effects, including digestion variability and ion suppression. The same work describes comparing results when the standard is added before versus after digestion, which estimates bias caused by peptide degradation during proteolysis. It also stresses that validation should assess linearity and potential interferences.
A validation checklist
| Parameter | What to test | What a problem suggests |
|---|---|---|
| Linearity and parallelism | Serial dilution of matrix samples against the calibration curve | Matrix effect, hook effect |
| Recovery | Spike at low, mid and high levels in matrix and in buffer | Matrix suppression, adsorption loss |
| Specificity | Related sequences, fragments and modified forms at relevant levels | Cross-reactivity |
| Sample stability | Freeze-thaw, bench-top and long-term storage | Degradation, aggregation |
| Carryover | Blank injection or well after the highest standard | Surface retention |
| Reference identity | COA, mass confirmation, sequence verification | Wrong or impure standard |
Reference material quality
The reference standard is a component the laboratory can select and characterize, but its concentration, stability and suitability still require evaluation. Impurities such as truncated or deletion sequences can cross-react in an immunoassay or co-elute in a chromatographic method, and an unverified concentration shifts every calibrator. Confirming identity and purity before the study begins is faster than diagnosing inconsistent curves afterward. Our overview of peptide sequence characterization methods describes the techniques commonly used, and the regulated peptide handling practices cover documentation and chain-of-custody expectations.
Perspective
In our experience, interference investigations take longest when the reference material is the unknown. If the identity, purity and batch of a peptide standard cannot be traced, every deviation in a curve has two possible explanations: the assay or the standard. Removing the second one at the outset shortens the work.
Review the product page and the available batch-specific Certificate of Analysis for the selected presentation. At Vertex Labs, documentation availability, test coverage and reported results vary by lot. Our published purity standard does not replace the findings of an individual laboratory report. A COA helps characterize the starting material, but its suitability as an assay reference still requires method-specific evaluation.
We also recommend that laboratories treat sourcing as part of assay design. Selecting a documented supplier, recording lot numbers beside every calibrator and keeping storage records are low-cost controls that make later troubleshooting more conclusive. Our custom sequence and bulk procurement services are intended to support the same continuity across long studies.
Vertex Labs Editorial Team
Documentation for traceable results
When a result is questioned months later, the following records answer most queries:
- Lot number and COA for every reference peptide and solution used
- Preparation date, solvent, storage temperature and number of freeze-thaw cycles
- Labware type and any surface treatment
- Calibrator matrix and the blank used
- Dilution scheme and results of dilution linearity
- Recovery data at the concentrations of interest
- Instrument settings, internal standard identity and acceptance criteria
- Any blocking reagent or enrichment step, with supplier and lot
Research groups running in vitro designs can pair this documentation with well-defined controls, as shown in our in-vitro peptide experiment examples. For concentration-response work in particular, a consistent calibrant and matrix across the whole series is what keeps the curve interpretable.
Research materials from Vertex Labs
We supply laboratory-grade research peptides, sterile and diluent solutions, peptide blends and custom sequences. Review the selected presentation and the available batch-specific COA; documentation and reported results vary by lot. Laboratories that need a consistent standard across multiple studies can also arrange bulk procurement. Browse the research catalog or review our high-purity research peptides and custom sequence services.
All products are intended exclusively for laboratory research. For Research Use Only. Not for human or veterinary use.
FAQ
What does assay interference mean?
Assay interference is any effect that makes a measured signal differ from what the target analyte alone would produce. It can raise or lower the reading, depending on the mechanism and format. The cause may be in the sample, the reagents or the handling before analysis.
What causes immunoassay interference?
Common causes include cross-reactivity, endogenous or heterophile antibodies, biotin, bilirubin and lipids, as summarized in a review of hormone immunoassay interference. The hook effect is limited to sandwich formats at very high analyte concentrations.
Is LC-MS/MS free of interference?
No. It avoids many antibody-related problems, but matrix effects such as ion suppression or enhancement can still alter results. Stable isotope-labeled internal standards and validated sample preparation are the usual controls.
How can I tell interference from a handling problem?
Repeat the measurement with a fresh aliquot and low-binding labware first. If the result normalizes, adsorption or degradation was the likely cause. If not, move to serial dilution, spike-recovery and an orthogonal method.
Sources
- Interferences in Immunoassay (PMC)
- Hormone Immunoassay Interference: A 2021 Update (PMC)
- Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS (PMC)
- Signal suppression/enhancement in high-performance liquid chromatography (ScienceDirect)
- Assay Artifacts in Peptide Research: Detection, Controls, and Troubleshooting
- Tutorial review for peptide assays (PubMed)
- From Lost in Translation to Paradise Found (PMC)
- Extreme Heterophilic Antibody Interference in BNP Immunoassay (PMC)
- Antibody Cross-Reactivity: Causes, Detection, and Fixes
- AimPlex Multiplex Assays